Clinical Trial Update: A Phase I Trial of AVN944, an IMPDH Inhibitor, in Adults With Advanced Stage Solid Tumors [NA]

View source ↗

Summary

This update reports the withdrawal of a Phase I trial of AVN944, an IMPDH inhibitor, in adults with advanced solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• AVN944

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Refractory Solid Tumors | NA | Status: WITHDRAWN